Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 42 matching records.
42 results — page 1 of 2
- Level AMeta-analysisEurope PMC
Efficacy and safety of stem cell therapy for myocardial infarction and heart failure: an updated systematic review and meta-analysis of randomized controlled trials
Meta-analysis with a reported sample of 3345 on Cardiovascular Disease, Stroke Research, published in Syst Rev (2026) — summary generated from the PubMed abstract.
- 2026
- n = 3345
Syst Rev - Level DNarrative ReviewEurope PMC
Two promising approaches in the treatment of myocardial infarction: stem cells and gene therapy
Narrative Review on Cardiovascular Disease, Stroke Research, published in Front Cardiovasc Med (2025) — summary generated from the PubMed abstract.
- 2025
Front Cardiovasc Med3 citations - Level DNarrative ReviewEurope PMC
Engineering functional electroconductive hydrogels for targeted therapy in myocardial infarction repair
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Bioact Mater (2025) — summary generated from the PubMed abstract.
- 2025
Bioact Mater8 citations - Level DNarrative ReviewEurope PMC
Post-myocardial Infarction Cardiac Remodeling: Multidimensional Mechanisms and Clinical Prospects of Stem Cell Therapy
Narrative Review on Cardiovascular Disease, Chronic Inflammation, published in Stem Cell Rev Rep (2025) — summary generated from the PubMed abstract.
- 2025
Stem Cell Rev Rep13 citations - Level BClinical TrialEurope PMC
Stem Cell Therapy for Myocardial Infarction Recovery: Advances, Challenges, and Future Directions
Clinical Trial on Cardiovascular Disease, published in Biomedicines (2025) — summary generated from the PubMed abstract.
- 2025
Biomedicines5 citations - Level DAnimal StudyPubMed
Low-intensity pulsed ultrasound as a strategy to boost exosome secretion by adipose-derived stem cells and uptake for myocardial infarction therapy.
Animal Study on Cardiovascular Disease, published in Biomed Mater (2025) — summary generated from the PubMed abstract.
- 2025
Biomed Mater1 citations - Level DNarrative ReviewEurope PMC
Emerging therapy strategies for energy metabolism in acute myocardial infarction
Narrative Review on Cardiovascular Disease, published in J Transl Med (2025) — summary generated from the PubMed abstract.
- 2025
J Transl Med4 citations - Level DAnimal StudyPubMed
Injectable and pH-Activated Self-Feedback Hydrogel Encapsulating Stem Cells for Augmented Acute Myocardial Infarction Therapy.
Animal Study on Cardiovascular Disease, published in Adv Healthc Mater (2025) — summary generated from the PubMed abstract.
- 2025
Adv Healthc Mater - Level DNarrative ReviewEurope PMC
Hydrogel based scaffolds in cardiovascular disease: applications in myocardial regeneration, biological pacing, and heart failure therapy
Narrative Review on Cardiovascular Disease, published in Front Cell Dev Biol (2025) — summary generated from the PubMed abstract.
- 2025
Front Cell Dev Biol - Level AMeta-analysisEurope PMC
Injectable hydrogel-based combination therapy for myocardial infarction: a systematic review and Meta-analysis of preclinical trials
Meta-analysis on Cardiovascular Disease, published in BMC Cardiovasc Disord (2024) — summary generated from the PubMed abstract.
- 2024
BMC Cardiovasc Disord15 citations - Level ASystematic ReviewPubMed
Stem Cell Therapy for Myocardial Infarction and Heart Failure: A Comprehensive Systematic Review and Critical Analysis.
Systematic Review on Cardiovascular Disease, published in Cureus (2024) — summary generated from the PubMed abstract.
- 2024
Cureus4 citations - Level DAnimal StudyEurope PMC
Macrophage-derived extracellular vesicles represent a promising endogenous iron-chelating therapy for iron overload and cardiac injury in myocardial infarction
Animal Study on Cardiovascular Disease, published in J Nanobiotechnology (2024) — summary generated from the PubMed abstract.
- 2024
J Nanobiotechnology12 citations - Level DNarrative ReviewEurope PMC
Genetically modified mesenchymal stromal cells: a cell-based therapy offering more efficient repair after myocardial infarction
Narrative Review on Cardiovascular Disease, Scar, Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
- 2024
Stem Cell Res Ther8 citations - Level DNarrative ReviewEurope PMC
Hydrogel-based cardiac patches for myocardial infarction therapy: Recent advances and challenges
Narrative Review on Cardiovascular Disease, published in Mater Today Bio (2024) — summary generated from the PubMed abstract.
- 2024
Mater Today Bio4 citations - Level BClinical TrialEurope PMC
Stem cell therapy for acute myocardial infarction: Mesenchymal Stem Cells and induced Pluripotent Stem Cells
Clinical Trial on Cardiovascular Disease, Scar, published in Expert Opin Biol Ther (2023) — summary generated from the PubMed abstract.
- 2023
Expert Opin Biol Ther24 citations - Level DNarrative ReviewEurope PMC
Signaling pathways and targeted therapy for myocardial infarction
Narrative Review on Cardiovascular Disease, published in Signal Transduct Target Ther (2022) — summary generated from the PubMed abstract.
- 2022
Signal Transduct Target Ther614 citations - Level DLaboratory StudyEurope PMC
Excessive branched-chain amino acid accumulation restricts mesenchymal stem cell-based therapy efficacy in myocardial infarction
Laboratory Study on Cardiovascular Disease, published in Signal Transduct Target Ther (2022) — summary generated from the PubMed abstract.
- 2022
Signal Transduct Target Ther44 citations - Level AMeta-analysisEurope PMC
Meta-Analysis of Percutaneous Endomyocardial Cell Therapy in Patients with Ischemic Heart Failure by Combination of Individual Patient Data (IPD) of ACCRUE and Publication-Based Aggregate Data
Meta-analysis with a reported sample of 8 on Cardiovascular Disease, published in J Clin Med (2022) — summary generated from the PubMed abstract.
- 2022
- n = 8
J Clin Med5 citations - Level DNarrative ReviewEurope PMC
The Progress of Stem Cell Therapy in Myocardial-Infarcted Heart Regeneration: Cell Sheet Technology
Narrative Review on Cardiovascular Disease, published in Tissue Eng Regen Med (2022) — summary generated from the PubMed abstract.
- 2022
Tissue Eng Regen Med7 citations - Level ASystematic ReviewEurope PMC
Multifunctional biomaterial platforms for blocking the fibrosis process and promoting cellular restoring effects in myocardial fibrosis therapy
Systematic Review on Cardiovascular Disease, published in Front Bioeng Biotechnol (2022) — summary generated from the PubMed abstract.
- 2022
Front Bioeng Biotechnol8 citations - Level BClinical TrialEurope PMC
Intervention effects of traditional Chinese medicine on stem cell therapy of myocardial infarction
Clinical Trial on Cardiovascular Disease, published in Front Pharmacol (2022) — summary generated from the PubMed abstract.
- 2022
Front Pharmacol7 citations - Level DNarrative ReviewEurope PMC
Exosomes as a Cell-free Therapy for Myocardial Injury Following Acute Myocardial Infarction or Ischemic Reperfusion
Narrative Review on Cardiovascular Disease, published in Aging Dis (2022) — summary generated from the PubMed abstract.
- 2022
Aging Dis15 citations - Level DLaboratory StudyPubMed
Cellular therapy for myocardial ischemia using a temperature-responsive biodegradable injectable polymer system with adipose-derived stem cells.
Laboratory Study on Cardiovascular Disease, published in Sci Technol Adv Mater (2021) — summary generated from the PubMed abstract.
- 2021
Sci Technol Adv Mater14 citations - Level DNarrative ReviewEurope PMC
Prospect of 3D bioprinting over cardiac cell therapy and conventional tissue engineering in the treatment of COVID-19 patients with myocardial injury
Narrative Review with a reported sample of 19 on Cardiovascular Disease, published in Regen Ther (2021) — summary generated from the PubMed abstract.
- 2021
- n = 19
Regen Ther4 citations
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406